BioMarin Adds Board Member
This article was originally published in Scrip
BioMarin Pharmaceutical Inc. has appointed former chair and CEO of Allergan, David Pyott, to its board of directors. Pyott was CEO of Allergan from 1998 to 2015 and was recognized by the Harvard Business Review as one of 'The 100 Best Performing CEOs in the World'. Prior to Allergan he was the head of Novartis nutrition division and a member of the executive committee of Novartis AG. Currently Pyott is lead director and board member of Avery Dennison Corporation and a board member of Alnylam Pharmaceuticals Inc.
Register for our free email digests: